2025-06-02 - LD Munich - Ascendis Pharma Growth Disorders et al. v. BioMarin Pharmaceutical et al. - UPC_CFI_18/2025; UPC_CFI_439/2025

1. The date for the interim conference via videoconference is set for 9 January 2026, 10.00 a.m. 2. Parties are invited to suggest topics for the interim conference by 19 December 2025. 3. The date for the oral hearing in person in Denisstr. 3 in Munich, room 212 and overflow room 220b, is set for 18 March 2026, 9.00 a.m. 4. Parties are summoned to these dates. 5. The panel will proceed with both, the infringement action and the counterclaim for revocation and therefore requests the President of the Court of First Instance to allocate a technically qualified judge out of the technical field of biotechnology to the panel. 6. The written procedure will end on 24 November 2025.

The Munich Local Division decided to hear both infringement action and counterclaim together, requested the allocation of a TQJ, scheduled the interim conference and the oral hearing, despite concerns regarding holidays expressed by one of the parties.